Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] - N0000192701

  1. Home
  2. Pharmacologic Class Index
  3. Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] - N0000192701

Pharmacologic Class Information

Pharmacologic Code N0000192701
Pharmacologic Name Lymphocyte Function-Associated Antigen-1 Antagonist
Pharmacologic Uses
  • lymphocyte function-associated antigen-1 (LFA-1) antagonist
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Lymphocyte Function-Associated Antigen-1 Antagonist

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Lymphocyte Function-Associated Antigen-1 Antagonist [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0078-0911Xiidra Non-Proprietary Name: LifitegrastSolution/ DropsOphthalmicNovartis Pharmaceuticals CorporationACTIVE